These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 11558580
1. Effect of modification of the carboxyl groups of the sialic acid binding lectin from bullfrog (Rana catesbeiana) oocyte on anti-tumor activity. Iwama M, Ogawa Y, Sasaki N, Nitta K, Takayanagi Y, Ohgi K, Tsuji T, Irie M. Biol Pharm Bull; 2001 Sep; 24(9):978-81. PubMed ID: 11558580 [Abstract] [Full Text] [Related]
2. Effect of replacing the aspartic acid/glutamic acid residues of bullfrog sialic acid binding lectin with asparagine/glutamine and arginine on the inhibition of cell proliferation in murine leukemia P388 cells. Ogawa Y, Iwama M, Ohgi K, Tsuji T, Irie M, Itagaki T, Kobayashi H, Inokuchi N. Biol Pharm Bull; 2002 Jun; 25(6):722-7. PubMed ID: 12081136 [Abstract] [Full Text] [Related]
3. Enzymatic properties of sialic acid binding lectin from Rana catesbeiana modified with a water-soluble carbodiimide in the presence of various nucleophiles. Iwama M, Ogawa Y, Ohgi K, Tsuji T, Irie M. Biol Pharm Bull; 2001 Dec; 24(12):1366-9. PubMed ID: 11767103 [Abstract] [Full Text] [Related]
4. Discovery of antitumor effects of leczymes. Tatsuta T, Hosono M. Glycoconj J; 2022 Apr; 39(2):157-165. PubMed ID: 35066741 [Abstract] [Full Text] [Related]
5. Synergistic anti-tumor effect of bullfrog sialic acid-binding lectin and pemetrexed in malignant mesothelioma. Satoh T, Tatsuta T, Sugawara S, Hara A, Hosono M. Oncotarget; 2017 Jun 27; 8(26):42466-42477. PubMed ID: 28476017 [Abstract] [Full Text] [Related]
6. Sialic Acid-Binding Lectin from Bullfrog Eggs Exhibits an Anti-Tumor Effect Against Breast Cancer Cells Including Triple-Negative Phenotype Cells. Tatsuta T, Sato S, Sato T, Sugawara S, Suzuki T, Hara A, Hosono M. Molecules; 2018 Oct 21; 23(10):. PubMed ID: 30347895 [Abstract] [Full Text] [Related]
7. Catalytic lectin (leczyme) from bullfrog (Rana catesbeiana) eggs. Nitta K, Ozaki K, Tsukamoto Y, Hosono M, Ogawakonno Y, Kawauchi H, Takayanagi Y, Tsuiki S, Hakomori S. Int J Oncol; 1996 Jul 21; 9(1):19-23. PubMed ID: 21541475 [Abstract] [Full Text] [Related]
8. Sialic acid-binding lectin from bullfrog eggs inhibits human malignant mesothelioma cell growth in vitro and in vivo. Tatsuta T, Satoh T, Sugawara S, Hara A, Hosono M. PLoS One; 2018 Jul 21; 13(1):e0190653. PubMed ID: 29298350 [Abstract] [Full Text] [Related]
9. [Basic Research on Bullfrog Egg-derived Sialic Acid-binding Lectin for Cancer Treatment]. Tatsuta T. Yakugaku Zasshi; 2022 Jul 21; 142(10):1045-1053. PubMed ID: 36184438 [Abstract] [Full Text] [Related]
10. Transcriptomic alterations in malignant pleural mesothelioma cells in response to long‑term treatment with bullfrog sialic acid‑binding lectin. Tatsuta T, Nakasato A, Sugawara S, Hosono M. Mol Med Rep; 2021 Jun 21; 23(6):. PubMed ID: 33880588 [Abstract] [Full Text] [Related]
11. Ribonuclease activity of sialic acid-binding lectin from Rana catesbeiana eggs. Nitta K, Oyama F, Oyama R, Sekiguchi K, Kawauchi H, Takayanagi Y, Hakomori S, Titani K. Glycobiology; 1993 Feb 21; 3(1):37-45. PubMed ID: 8448385 [Abstract] [Full Text] [Related]
12. Large-scale preparation of a ribonuclease from Rana catesbeiana (bullfrog) oocytes and characterization of its specific cytotoxic activity against tumor cells. Liao YD, Huang HC, Chan HJ, Kuo SJ. Protein Expr Purif; 1996 Mar 21; 7(2):194-202. PubMed ID: 8812861 [Abstract] [Full Text] [Related]
13. Leczyme: a new candidate drug for cancer therapy. Tatsuta T, Sugawara S, Takahashi K, Ogawa Y, Hosono M, Nitta K. Biomed Res Int; 2014 Mar 21; 2014():421415. PubMed ID: 24864241 [Abstract] [Full Text] [Related]
14. Inhibition of cell proliferation by Rana catesbeiana and Rana japonica lectins belonging to the ribonuclease superfamily. Nitta K, Ozaki K, Ishikawa M, Furusawa S, Hosono M, Kawauchi H, Sasaki K, Takayanagi Y, Tsuiki S, Hakomori S. Cancer Res; 1994 Feb 15; 54(4):920-7. PubMed ID: 8313382 [Abstract] [Full Text] [Related]
15. Sialyl-glycoconjugates in cholesterol-rich microdomains of P388 cells are the triggers for apoptosis induced by Rana catesbeiana oocyte ribonuclease. Ogawa Y, Sugawara S, Tatsuta T, Hosono M, Nitta K, Fujii Y, Kobayashi H, Fujimura T, Taka H, Koide Y, Hasan I, Matsumoto R, Yasumitsu H, Kanaly RA, Kawsar SM, Ozeki Y. Glycoconj J; 2014 Feb 15; 31(2):171-84. PubMed ID: 24271942 [Abstract] [Full Text] [Related]
16. Characterization of a Rana catesbeiana lectin-resistant mutant of leukemia P388 cells. Nitta K, Ozaki K, Tsukamoto Y, Furusawa S, Ohkubo Y, Takimoto H, Murata R, Hosono M, Hikichi N, Sasaki K. Cancer Res; 1994 Feb 15; 54(4):928-34. PubMed ID: 8313383 [Abstract] [Full Text] [Related]
17. A pyrimidine-guanine sequence-specific ribonuclease from Rana catesbeiana (bullfrog) oocytes. Liao YD. Nucleic Acids Res; 1992 Mar 25; 20(6):1371-7. PubMed ID: 1373237 [Abstract] [Full Text] [Related]
18. The Rana catesbeiana rcr gene encoding a cytotoxic ribonuclease. Tissue distribution, cloning, purification, cytotoxicity, and active residues for RNase activity. Huang HC, Wang SC, Leu YJ, Lu SC, Liao YD. J Biol Chem; 1998 Mar 13; 273(11):6395-401. PubMed ID: 9497370 [Abstract] [Full Text] [Related]
19. Purification, and properties of a base non-specific acid ribonuclease from bullfrog (Rana catesbeiana). Yagi H, Kobayashi H, Inokuchi N, Koyama T, Irie M. Biol Pharm Bull; 1995 Feb 13; 18(2):219-22. PubMed ID: 7742787 [Abstract] [Full Text] [Related]
20. Comparative base specificity, stability, and lectin activity of two lectins from eggs of Rana catesbeiana and R. japonica and liver ribonuclease from R. catesbeiana. Okabe Y, Katayama N, Iwama M, Watanabe H, Ohgi K, Irie M, Nitta K, Kawauchi H, Takayanagi Y, Oyama F. J Biochem; 1991 May 13; 109(5):786-90. PubMed ID: 1917903 [Abstract] [Full Text] [Related] Page: [Next] [New Search]